Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling
| Image |  |
|---|---|
| Description | scientific article published on 27 July 2019 |
| Author/s |
author: Hiu Yee Kwan |
| Publication date | July 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |